8-K - Maze Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Financing

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On February 4, 2026 (the “ Closing Date ”), Maze Therapeutics, Inc. (the “ Company ”) entered into that certain Lo

Material Agreement

$200.0M$40.0M$160.0M$50.0M

1.02

Termination of a Material Definitive Agreement Termination of Banc of California Loan and Security Agreement In connection with the entry into the Hercules Loan

Material Agreement

2.03

by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its beh

Financing

Exhibits (1)

8-K